FMP
Icosavax, Inc.
ICVX
NASDAQ
Inactive Equity
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was incorporated in 2017 and is headquartered in Seattle, Washington.
15.31 USD
-0.14 (-0.914%)
About
ceo
Mr. Adam K. Simpson
sector
Healthcare
industry
Biotechnology
website
https://icosavax.com
exchange
NASDAQ
Description
Icosavax, Inc., a biopharmaceutical company, develops vaccines against infectious diseases. The company, with the help of its virus-like particle (VLP) platform technology, focuses primarily on life-threatening respiratory diseases. Its products in pipeline include IVX-121, a vaccine candidate with RSV target and is under Phase 1/1b clinical trial; IVX-A12, a respiratory syncytial virus (RSV) monovalent antigen candidate with RSV/human metapneumovirus (hMPV) bivalent target indication; IVX-241, a vaccine candidate with hMPV target; and IVX-411, an original receptor binding domain (RBD) sequence antigen with SARS-CoV-2 target indication and is under Phase 1/2 clinical trial. The company was i...
CIK
0001786255
ISIN
KR7002780005
CUSIP
45114M109
Address
1616 Eastlake Avenue East
Phone
206 737 0085
Country
US
Employee
60
IPO Date
Jul 29, 2021
Summary
CIK
0001786255
Exchange
NASDAQ
Industry
Biotechnology
Sector
Healthcare
CUSIP
45114M109
ISIN
KR7002780005
Country
US
Price
15.31
Beta
1.28
Volume Avg.
1.05M
Market Cap
769.04M
Shares
-
52-Week
4.75-16.105
DCF
1.26
ROE
-
ROA
-
Operating Margin
-
Debt/Equity
-
P/E
-6.96
P/B
-
Website
https://icosavax.com
Historical Prices
We are unable to load the chart at this time.
Financial Statement
We are unable to load the chart at this time.
Earnings
We are unable to load the chart at this time.
Upgrades and Downgrades
We are unable to load this data!
People Also Watch
Financial Information
Financial Summary Real-Time Price
Financial Statements
Financial Quarter Statements
Ratios Analysis
Dupont Analysis
Free Cashflow
Operating Data
Balance Sheet Data
Financial Modelling
Discounted Cashflow Model
Discounted Cashflow Model Levered
Free Cashflow Build-Up
Terminal Value
Intrinsic Value
Weighted Average Cost of Capital
Market Information
Stock Value
Latest ICVX News
It looks like there's no news available.
